Tokyo Tape
Sign in
← Meiji Holdings

Quarterly report · Q2

2269.TEDINET S100S7SR
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥546.0bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥1.06T2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥517.5bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥44.4bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥43.2bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥43.4bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥74.2bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥43.9bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥48.1bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥48.3bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥27.9bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥69.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥33.4bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥30.4bn2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥34.9bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥1.21Tat 2023-09-30Cons.Assets
Total assets¥1.14Tat 2023-03-31Cons.Assets
Total assets¥1.18Tat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥421.1bnat 2023-09-30Cons.Liabilities
Total liabilities¥384.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥786.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥751.3bnat 2023-03-31Cons.Net assets
Net assets / equity¥757.0bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥82.1bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥63.5bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥78.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥88.7bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥25.9bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥85.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥25.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥15.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥36.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥26.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥4.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥54.7bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥20.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥100.132023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.542023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥247.392022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥118.522022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥61.652022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio61.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio62.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio60.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥303m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥303m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥1.1bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2023-04-01 → 2023-09-30¥445.5bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2023-04-01 → 2023-09-30¥445.2bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥293m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2023-04-01 → 2023-09-30¥29.7bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2023-04-01 → 2023-09-30¥100.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2023-04-01 → 2023-09-30¥100.8bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥9m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2023-04-01 → 2023-09-30¥15.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥546.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥546.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥303m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥45.6bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥292m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥292m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥786m
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2022-04-01 → 2022-09-30¥420.6bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2022-04-01 → 2022-09-30¥420.4bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥278m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2022-04-01 → 2022-09-30¥29.3bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2022-04-01 → 2022-09-30¥97.2bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2022-04-01 → 2022-09-30¥97.2bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥13m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2022-04-01 → 2022-09-30¥14.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥517.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥517.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥292m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥44.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 552
ItemContextValueUnit
Other ioaCurrentQuarterInstant7771000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-63000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-75000000JPY
Investments and other assetsPrior1YearInstant156046000000JPY
Investments and other assetsCurrentQuarterInstant160267000000JPY
Noncurrent assetsPrior1YearInstant665298000000JPY
Noncurrent assetsCurrentQuarterInstant669756000000JPY
AssetsPrior1YearInstant1136217000000JPY
AssetsCurrentQuarterInstant1207796000000JPY
Notes and accounts payable tradePrior1YearInstant112312000000JPY
Notes and accounts payable tradeCurrentQuarterInstant123979000000JPY
Short term loans payablePrior1YearInstant4874000000JPY
Short term loans payableCurrentQuarterInstant24827000000JPY
Current portion of bondsPrior1YearInstant10000000000JPY
Current portion of bondsCurrentQuarterInstant10000000000JPY
Accrued expensesPrior1YearInstant34994000000JPY
Accrued expensesCurrentQuarterInstant36188000000JPY
Income taxes payablePrior1YearInstant11299000000JPY
Income taxes payableCurrentQuarterInstant15988000000JPY
Contract liabilitiesPrior1YearInstant870000000JPY
Contract liabilitiesCurrentQuarterInstant535000000JPY
Return liabilityPrior1YearInstant18052000000JPY
Return liabilityCurrentQuarterInstant18593000000JPY
Provision for bonusesPrior1YearInstant11375000000JPY
Provision for bonusesCurrentQuarterInstant10429000000JPY
Other clPrior1YearInstant62478000000JPY
Other clCurrentQuarterInstant62053000000JPY
Current liabilitiesPrior1YearInstant266258000000JPY
Current liabilitiesCurrentQuarterInstant302597000000JPY
Bonds payablePrior1YearInstant10000000000JPY
Bonds payableCurrentQuarterInstant10000000000JPY
Long term loans payablePrior1YearInstant39496000000JPY
Long term loans payableCurrentQuarterInstant37482000000JPY
Deferred tax liabilitiesPrior1YearInstant5497000000JPY
Deferred tax liabilitiesCurrentQuarterInstant5397000000JPY
Net defined benefit liabilityPrior1YearInstant56255000000JPY
Net defined benefit liabilityCurrentQuarterInstant56877000000JPY
Provision for directors retirement benefitsPrior1YearInstant76000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant73000000JPY
Other nclPrior1YearInstant7322000000JPY
Other nclCurrentQuarterInstant8681000000JPY
Noncurrent liabilitiesPrior1YearInstant118647000000JPY
Noncurrent liabilitiesCurrentQuarterInstant118513000000JPY
LiabilitiesPrior1YearInstant384905000000JPY
LiabilitiesCurrentQuarterInstant421110000000JPY
Capital stockPrior1YearInstant30000000000JPY
Capital stockCurrentQuarterInstant30000000000JPY
Capital surplusPrior1YearInstant80609000000JPY
Capital surplusCurrentQuarterInstant72409000000JPY
Retained earningsPrior1YearInstant602042000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass